Trial NCT02648633

View at ClinicalTrials.gov 
Org. Study IDs: 18574
Secondary IDs: CA209-378

Last trial update was posted on 2017-05-31

MeSH Interventions

Nivolumab Valproic Acid

MeSH Conditions

Glioblastoma

Other Conditions


Stopping Reasons

The pharmaceutical company (BMS) would no longer provide nivolumab for the study, so the study was terminated early.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID